News
(HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is valid for predicting radiotherapy (RT)-induced genitourinary (GU) toxicity in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback